Stock APGE APOGEE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Apogee Therapeutics, Inc.

Equities

APGE

US03770N1019

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
41.14 USD -4.59% Intraday chart for Apogee Therapeutics, Inc. -1.32% +47.24%
May. 28 Apogee Therapeutics, Inc. Appoints Lisa Bollinger to Its Board of Directors CI
May. 15 Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
APOGEE THERAPEUTICS, INC. Stock Apogee Therapeutics, Inc.
 2.4B - - - - -
MODERNA, INC. Stock Moderna, Inc.
 53.67B -
LONZA GROUP AG Stock Lonza Group AG
 38.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.76B
CELLTRION, INC. Stock Celltrion, Inc.
 27.27B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.91B
  1. Stock Market
  2. Equities
  3. APGE Stock
  4. Charts Apogee Therapeutics, Inc.
  5. Sector Chart